Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded down 13% during trading on Wednesday . The company traded as low as GBX 2 ($0.02) and last traded at GBX 2 ($0.02). 3,474,834 shares were traded during mid-day trading, an increase of 16% from the average session volume of 3,001,732 shares. The stock had previously closed at GBX 2.30 ($0.03).
Cizzle Biotechnology Trading Up 1.8 %
The company has a market cap of £7.47 million, a PE ratio of -188.40 and a beta of 0.38. The firm’s 50-day simple moving average is GBX 1.79 and its two-hundred day simple moving average is GBX 1.86.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- The Basics of Support and Resistance
- Market Volatility Ahead? These 3 ETFs Stand Out
- How to Evaluate a Stock Before Buying
- Bank Stocks Are on Fire; Here’s Where the Action Is Smoking Hot
- EV Stocks and How to Profit from Them
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
